STABLE ISOTOPE

Methotrexate EP Impurity D

TMM-115004
Methotrexate EP Impurity D
4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzoic acid;N10-Methyl Pteroic Acid;Methotrexate Impurity D;N10-Methyl Pteroic A;10-methyl-pteroic acid;10-Methyl-pteroinsaeure;Benzoic acid, p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)methylamino)-;BENZOIC ACID, p-((N-(2-AMINO-4-HYDROXY)PTERIDIN-6-YLMETHYL)-N-METHYLAMINO)-;Benzoic acid, p-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]methylamino]-;BRN 0338741;Metfol-B;n(10)-Methyl pteroic acid;p-((N-(2-Amino-4-hydroxy)pteridin-6-ylmethyl)-N-methylamino)benzoic acid;Pteroic acid, N10-methyl-;4-{[(2-Amino-4-hydroxypteridin-6-yl)methyl]methylamino}benzoic acid Open
5623-18-7
C15H14N6O3
326.32
Product name Methotrexate EP Impurity D
Chinese Name Methotrexate EP Impurity D
CAS# 5623-18-7
EINECS
MDL
Molecular Formula C15H14N6O3
Molecular Weight 326.32
Hazard Statements
Precautionary Statements
GHS Pictogram
Melting Point
Boiling Point
Molecular Formula C15H14N6O3
Flash Point
Molecular Weight 326.32
Density
Storage

Related Products

TMA-601215 Methadone Impurity C
CAS No. 6293-01-2
M.F. :C19H22N2
M.W. :278.39
TMA-601145 Mesalazine EP Impurity D
CAS No. 99-05-8
M.F. :C7H7NO2
M.W. :137.14
TMA-600549 (E)-3-(3,4-difluorophenyl)acrylaldehyde
CAS No. 1334528-90-3
M.F. :C9H6F2O
M.W. :168.14
TMA-600471 Capecitabine Impurity B(USP)
CAS No. 3094-09-5
M.F. :C9H11FN2O5
M.W. :246.19
TMA-600341 Benzenesulfonamide
CAS No. 98-10-2
M.F. :C6H7NO2S
M.W. :157.19
TMA-600298 Bendamustine Impurity 50
CAS No. 5367-52-2
M.F. :C8H11N3O2
M.W. :181.19
TMA-601738 Stearic Acid
CAS No. 57-11-4
M.F. :C18H36O2
M.W. :284.48
TMA-601534 Palmitic Acid
CAS No. 57-10-3
M.F. :C16H32O2
M.W. :256.42
TMA-600404 Clotrimazole EP Impurity E
CAS No. 5162-03-8
M.F. :C13H9CLO
M.W. :216.66
TMA-601998 Zoledronic Acid EP Impurity B Dihydrate
CAS No. 1627731-61-6
M.F. :C7N2O14P4H16
M.W. :476.10